mRNA and microRNA Approaches to Stain Age

In circulating blood, RNA is produced and regulated in a dynamic equilibrium. Red blood cells lose their nucleus during maturation and contain no DNA, but reticulocytes (immature red cells) and white blood cells (leukocytes) are transcriptionally active and carry messenger RNA and non-coding RNA species. Platelets also carry RNA despite having no nucleus, derived from megakaryocyte cytoplasm during formation.

When blood is shed, the regulatory environment collapses. RNases, which in living cells are sequestered in lysosomes or extracellular compartments, come into contact with cytoplasmic RNA as cell membranes disrupt during drying and death. Plasma also contains abundant RNase A, which begins degrading extracellular RNA immediately. The result is that RNA in shed blood has a half-life on the order of minutes to hours for many species under warm conditions, compared with DNA, which can persist for decades in dry deposits.

The forensic opportunity is this: if you measure how much of a specific RNA species remains at the time of analysis, and if you know its starting abundance and degradation rate, you can in principle back-calculate when the stain was deposited. The challenge is that both starting abundance and degradation rate vary between individuals and between environments, and those sources of variability interact in ways that current models cannot fully capture.

The earliest molecular RNA work on forensic body-fluid stains focused on tissue-type identification rather than ageing. Groups including Juusola and Ballantyne (2005) demonstrated that mRNA profiling could identify blood, saliva, vaginal secretions, and semen by detecting body-fluid-specific transcripts. From there, the logical extension was to ask whether mRNA levels could also indicate stain age.

Full-length mRNA transcripts range from a few hundred to several thousand nucleotides. Longer transcripts degrade faster under the same conditions. Researchers including Bauer and colleagues noted that the ratio of an intact mRNA signal to its degraded fragments, or the ratio of a more-stable short transcript to a less-stable long one, changed predictably over time in controlled experiments. These ratio metrics (sometimes called degradation indices) were proposed as age markers.

microRNAs (miRNAs) are a class of small non-coding RNA molecules, typically 18-24 nucleotides in length, that regulate gene expression by binding to complementary sequences in target mRNA and inhibiting translation or promoting degradation. They are abundant in blood: over 500 distinct miRNA species have been detected in human plasma and peripheral blood cells. Their small size confers relative resistance to nuclease cleavage compared with full-length mRNA, and some species are selectively protected by association with proteins (RISC complex, Argonaute proteins) or packaged into exosomes that provide additional protection from RNases.

These properties make specific miRNA species viable candidates as markers that remain detectable in stains several days to weeks old while still exhibiting measurable degradation for temporal inference. The most studied species for bloodstain ageing include miR-let-7b (one of the most abundant miRNAs in whole blood), miR-16 (broadly expressed in haematopoietic cells), and miR-451 (highly expressed in erythrocytes). Each shows a different degradation trajectory, and research groups have proposed using the ratio of a more-stable species to a less-stable one as a degradation index that normalises for the starting amount.

Measuring RNA in a dried bloodstain requires getting RNA out of the stain, converting it to cDNA, and then quantifying specific species by real-time PCR. Each step must be adapted to the challenges of a forensic sample, which may be small, mixed with substrate fibres, and partially degraded.

1. Extraction
   A portion of the stain (typically a 4 mm punch from fabric, or a scraping from a non-porous surface) is rehydrated and lysed in a guanidinium-thiocyanate or similar chaotropic buffer that simultaneously denatures RNases and solubilises the stain matrix. Silica-column or magnetic-bead purification then captures RNA. Simultaneous extraction of DNA is possible, making combined STR typing and RNA analysis feasible from a single small sample.
2. Reverse transcription
   Extracted RNA is converted to complementary DNA (cDNA) by reverse transcriptase primed with either random hexamers (for mRNA) or miRNA-specific stem-loop primers (for individual miRNA species). The reverse transcription step is critical: inefficient RT artificially raises apparent Ct values and can masquerade as degradation.
3. Quantitative PCR
   The cDNA is amplified using TaqMan or SYBR-green qPCR assays targeting the specific miRNA or mRNA of interest. The cycle threshold (Ct) value is recorded. Lower Ct means more starting RNA. A fresh stain gives a lower Ct for the target species; an old stain gives a higher Ct (less RNA) or no amplification.
4. Normalisation and ratio calculation
   Raw Ct values are normalised against a reference species assumed to be stable (though choosing a stable reference in a degrading sample is itself methodologically challenging). The ratio of a fast-degrading species to a slow-degrading species provides the degradation index, which is then compared to a calibration curve built from stains of known age.

Published studies consistently show that miRNA degradation indices change with stain age under controlled conditions. The forensic validation question is whether that change can be predicted accurately enough across the full range of conditions encountered in real casework. Three sources of variability dominate the literature.

• Inter-individual variation. Plasma RNase activity levels differ substantially between donors. Blood from donors with elevated RNase activity (which can result from infection, autoimmune conditions, or simply normal biological variation) degrades faster than blood from low-activity donors. Studies that use pooled or single-donor blood therefore underestimate the range of degradation rates seen across a population.
• Environmental variation. Temperature is the strongest environmental driver. At 37°C, miRNA degrades several times faster than at 4°C. Humidity affects drying speed, which in turn affects how quickly the stain transitions from an aqueous environment (where RNases are active) to a dry state (where activity slows). Outdoor stains exposed to UV also show faster RNA degradation. No single calibration curve captures all combinations.
• Substrate variation. Absorbent substrates promote faster drying and often contain compounds (tannins in natural fibres, processing chemicals in synthetics) that can inhibit RT-qPCR assays, artificially increasing apparent degradation. Non-porous substrates allow a thicker wet stain that degrades more slowly but may inhibit complete extraction.

Recent research has addressed variability by using panels of multiple miRNA species rather than a single marker; the combined degradation behaviour of many species with differing kinetics contains more temporal information than any single ratio. Machine learning models trained on multi-marker panels have shown improved performance in controlled datasets, though independent validation across donors and environments remains limited.

A second direction is the use of RNA sequencing (RNA-seq) to profile hundreds of species simultaneously. This allows researchers to identify species with particularly consistent degradation kinetics across donors, a process called biomarker discovery, which feeds back into the design of targeted RT-qPCR assays. Work by Courts and Madea (2010) and by Bauer and colleagues (2009-2013) laid early groundwork. More recent work, including contributions from groups in Germany, the UK, and the USA, has refined the marker set and begun addressing inter-donor variability directly by building models that estimate and correct for donor-specific RNase activity using internal reference species.

Proficiency testing across multiple laboratories has not yet been published for RNA ageing methods, in contrast to DNA profiling where extensive inter-laboratory studies underpin accreditation. Until proficiency testing exists, the method's error rate under real casework conditions cannot be stated with the precision that regulatory bodies require. The path to casework acceptance runs through inter-laboratory studies, not just further single-laboratory refinements.

The same RNA extraction used for ageing can yield information about the body-fluid source of the stain. Blood, saliva, vaginal secretions, semen, and menstrual blood each have characteristic mRNA and miRNA expression profiles. An analyst can confirm that a stain is blood and obtain degradation-index information from the same sample.

This means RNA analysis is not pursued purely for ageing information. In a well-resourced laboratory, an RNA screen that confirms body-fluid identity and simultaneously provides degradation-index data has value even if the ageing resolution is coarse. The ageing information supports (or challenges) the scene reconstruction without claiming precision the method cannot support. Framing the result as contributory intelligence rather than a definitive estimate is currently the most defensible approach when presenting RNA ageing data in a forensic report.